Astoria Portfolio Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
OIA
TA
LFAS
Astoria Portfolio Advisors's BTAL Position: Q2 2025 in Review
Astoria Portfolio Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2025, closing a stake of 93,955 shares — an estimated $1.94M sold.
Astoria Portfolio Advisors first reported a position in BTAL in Q4 2021 and held it in 11 quarters. The position peaked at $5.69M in Q1 2023. 80 funds tracked by Wall St. Rank hold BTAL as of Q2 2025.
- Astoria Portfolio Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2025 after selling out during the quarter.
- Astoria Portfolio Advisors sold 93,955 AGF US Market Neutral Anti-Beta Fund shares in Q2 2025, an estimated $1.94M.
- Astoria Portfolio Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2021 and held it in 11 quarters.
- Astoria Portfolio Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $5.69M in Q1 2023.
- 80 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2025.
Based on Astoria Portfolio Advisors's 13F filing for Q2 2025, filed 25 Jul 2025.